Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan

Study Objectives: Diabetes mellitus per se and its related therapy have been frequently associated with an increased risk of developing dementia. However, studies that explored the risk of dementia from the use of the novel oral antidiabetic medication dipeptidyl peptidase 4 inhibitor (DPP-4i) have...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Med
Main Authors: Chen, Kuan-Chan, Chung, Chi-Hsiang, Lu, Chieh-Hua, Tzeng, Nian-Sheng, Lee, Chien-Hsing, Su, Sheng-Chiang, Kuo, Feng-Chih, Liu, Jhih-Syuan, Hsieh, Chang-Hsun, Chien, Wu-Chien
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141309/
https://ncbi.nlm.nih.gov/pubmed/32121372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9030660
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki